FINDINGS OF A LITERATURE REVIEW IN SUPPORT OF A PATIENT COUNT MODEL (PCM) FOR HEPATITIS C VIRUS (HCV) IN THE EU5
Author(s)
Gueron B1, Nalpas C1, Maiese BA2, Cadarette SM2, Campbell DJ2, Arvin-berod C3, Duchesne I4
1Janssen Pharmaceuticals, Paris, France, 2Xcenda, Palm Harbor, FL, USA, 3Xcenda Switzerland GmbH, Bern, Switzerland, 4Janssen EMEA, Beerse, Belgium
OBJECTIVES:
Conference/Value in Health Info
2016-10, ISPOR Europe 2016, Vienna, Austria
Value in Health, Vol. 19, No. 7 (November 2016)
Code
PIN15
Topic
Epidemiology & Public Health
Disease
Infectious Disease (non-vaccine)
Your browser is out-of-date
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now